113 filings
8-K
VRPX
Virpax Pharmaceuticals Inc
17 May 24
Virpax Announces Pricing of $2.25 Million Public Offering
4:05pm
424B4
VRPX
Virpax Pharmaceuticals Inc
16 May 24
Prospectus supplement with pricing info
4:00pm
EFFECT
VRPX
Virpax Pharmaceuticals Inc
15 May 24
Notice of effectiveness
12:15am
S-1/A
VRPX
Virpax Pharmaceuticals Inc
IPO registration (amended)
13 May 24
5:30pm
8-K
VRPX
Virpax Pharmaceuticals Inc
13 May 24
Virpax Pharmaceuticals Reports 2024 First Quarter Results and Recent Developments
4:20pm
8-K
p63uejp
2 May 24
Departure of Directors or Certain Officers
4:00pm
8-K
6pt74
30 Apr 24
Other Events
7:35am
S-8
i5zviij9fkml 3d
5 Apr 24
Registration of securities for employees
4:05pm
8-K
q0bjo5ofpo
3 Apr 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:05pm
8-K
nhzlflw0qirzkkz2y2
26 Mar 24
Virpax Pharmaceuticals Reports 2023 Year-End Results
7:30am
8-K
wba1wv 3b3f
18 Mar 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
6:30am
8-K
2r8z03gsmpi3rccf0
1 Mar 24
Virpax Pharmaceuticals Announces Reverse Stock
4:05pm
8-K
dhlwlniwkeoo62h5t
29 Dec 23
Submission of Matters to a Vote of Security Holders
7:30am
8-K
qbivxq3jxrtzay54d3
13 Dec 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
8:30am